Home Tags Medicinal cannabis

Tag: medicinal cannabis

ECS Botanics completes maiden cannabis shipment to the UK

Australian medicinal cannabis and hemp company ECS Botanics has completed its maiden shipment of dried cannabis flower to Lyphe Group, the largest distributor of...

Little Green Pharma unveils plans to manufacture psychedelic medicines in WA

Australian medicinal cannabis producer Little Green Pharma (LGP) has successfully cleared a major hurdle for entering the field of psychedelic medicine with the grant...

ECS Botanics secures a 4-year agreement with MW Pharma Limited

Australian medicinal cannabis and industrial hemp company ECS Botanics has signed a four-year agreement to supply GMP manufactured medicinal cannabis products to MW Pharma...

Cann Group wraps up acquisition of Satipharm

Cann Group Limited (ASX: CAN) has completed the acquisition of the Satipharm business from Harvest One Cannabis Inc. for CAD$4 million, including conditional deferred...

Cann Group supplies medicinal cannabis for Australian clinical trial for advanced cancer patients

Cann Group Limited is supplying medicinal cannabis for Australian clinical trial assessing quality of life impacts for advanced cancer patients. The trial, which is being...

ECS Botanics’ Murray Meds inks supply agreement with Australian cannabinoid company

ECS Botanics Holdings Ltd (ASX:ECS), through Murray Meds, has entered a three-year agreement with an undisclosed Australian cannabinoid company for the supply of medicinal...

Releaf Group set to acquire medicinal cannabis manufacturer Cannoz

Releaf Group Ltd's wholly owned subsidiary Releaf Manufacturing Pty Ltd has inked an agreement to acquire 51% interest in licensed cannabis manufacturer Perfect Capital...

CSIRO now set to develop new medicinal cannabis products

CSIRO will work hand-in-hand with local manufacturers to develop new medicinal cannabis therapeutics – a move that will also make room in the local...

Researchers on a quest to find out how medicinal cannabis affects long-term patients

The QUality of life Evaluation STudy (The QUEST Initiative), funded by LGP, will investigate how prescribed medicinal cannabis affects quality-of-life outcomes for patients. Researchers at...

Cann Group moves to acquire Satipharm with Share Sale Agreement

The acquisition will fast-track the development of medicinal cannabis delivery systems and formulations to be sold over-the-counter across Australia. Cann Group Limited (ASX:CAN) has signed...
Advertisement

Simple Benchtops

AGM Automation

Featured Article

Accelerate your Journey to Scale AM Production

Sponsored Content by Additive manufacturing (AM) has the power to completely transform manufacturing businesses. According to a study by Jabil, up to 90% of manufacturers believe that additive manufacturing is essential to future-proofing their...